<i>In vitro</i>and<i>in vivo</i>evaluation of silybin nanosuspensions for oral and intravenous delivery

Yancai Wang,Dianrui Zhang,Zhaoping Liu,Guangpu Liu,Cunxian Duan,Lejiao Jia,Feifei Feng,Xiaoyu Zhang,Yanqiu Shi,Qiang Zhang
DOI: https://doi.org/10.1088/0957-4484/21/15/155104
IF: 3.5
2010-01-01
Nanotechnology
Abstract:In this study, we evaluate the effect of particle sizes on the physicochemical properties of silybin and identify the influence of silybin nanosuspensions on its permeation across the Caco-2 cell monolayer. In vivo pharmacokinetic evaluation of silybin nanosuspensions was also carried out in beagle dogs. TEM, AFM and SEM analyses revealed the effect of homogenization pressure on particle size and morphology, and confirmed the existence of a surfactant-stabilizer film on the surface of nanoparticles. DSC and XRPD experiments manifested that the crystalline state was maintained as particle size was reduced and the enhanced dissolution property was due to the increased surface area. Nanosuspensions had a significant influence on drug transport across the Caco-2 cell monolayer and the enhanced dissolution velocity was responsible for the increased permeability. A pharmacokinetics study in beagle dogs further confirmed the in vitro results and demonstrated that oral administration of silybin nanosuspensions significantly increase its bioavailability compared to the coarse powder. Nanosuspensions of silybin with smaller particle size reveal a higher potential to increase their oral bioavailability; while for intravenous infusion the lower pressure produced silybin nanosuspensions appeared to maintain a more sustained drug release profile.
What problem does this paper attempt to address?